Skip NavigationSkip to Content
Return Return to Search Results

Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions

  1. Author:
    Xu, H. Z.
    Chertova, E.
    Chen, J. B.
    Ott, D. E.
    Roser, J. D.
    Hu, W. S.
    Pathak, V. K.

  2. Author Address

    Natl Canc Ctr, Ctr Canc Res, Viral Mutat Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA. Natl Canc Inst, SAIC Frederick Inc, AIDS Vaccine Program, Frederick, MD 21702 USA. Natl Canc Inst, Viral Recominat Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA.;Pathak, VK, Natl Canc Ctr, Ctr Canc Res, Viral Mutat Sect, HIV Drug Resistance Program, POB B,Bldg 535,Rm 334, Frederick, MD 21702 USA.;vpathak@ncifcrf.gov
    1. Year: 2007
    2. Date: Apr
  2. Journal: Virology
    1. 360
    2. 2
    3. Pages: 247-256
  4. Type of Article: Article
  5. ISSN: 0042-6822
  1. Abstract:

    A host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency virus type I (HIV-1) by incorporating into virions in the absence of the virally encoded Vif protein (Delta vif virions), at least in part by causing G-to-A hypermutation. To gain insight into the antiretroviral function of A3G, we determined the quantities of A3G molecules that are incorporated in Delta vif virions. We combined three experimental approaches-reversed-phase high-pressure liquid chromatography (HPLC), scintillation proximity assay (SPA), and quantitative immunoblotting-to determine the molar ratio of A3G to HIV-1 capsid protein in Delta vif virions. Our studies revealed that the amount of the A3G incorporated into Delta vif virions was proportional to the level of its expression in the viral producing cells, and the ratio of the A3G to Gag in the Delta vif virions produced from activated human peripheral blood mononuclear cells (PBMC) was approximately 1:439. Based on previous estimates of the stoichiometry of HIV-1 Gag in virions (1400-5000), we conclude that approximately 7 (+/- 4) molecules of A3G are incorporated into Delta vif virions produced from human PBMCs. These results indicate that virion incorporation of only a few molecules of A3G is sufficient to inhibit HIV-1 replication. Published by Elsevier Inc.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.virol.2006.10.036
  3. View record in Web of Science®
  4. WOS: 000245566100001

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel